Gain-of-function somatic mutations of SET binding protein 1 (SETBP1) result in the accumulation of SETBP protein and are detected in 17% of secondary acute myeloid leukemia (AML) patients.1 This evidence concerns the gene SETBP1 and acute myeloid leukemia.